Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole

Anncaliia algerae myositis is a life-threatening, emerging microsporidiosis among immunocompromised hosts. We report a case of disseminated A algerae infection in a man previously treated with alemtuzumab. Due to failure of albendazole-based therapy, fumagillin was added as a novel approach to management, with a good clinical response and patient survival.

[1]  M. Santiana,et al.  Analysis of the Beta‐Tubulin Gene and Morphological Changes of the Microsporidium Anncaliia algerae both Suggest Albendazole Sensitivity , 2015, The Journal of eukaryotic microbiology.

[2]  B. Pritt,et al.  Extraintestinal Microsporidiosis , 2014, Journal of Clinical Microbiology.

[3]  D. Stark,et al.  Anncaliia algerae Microsporidial Myositis , 2014, Emerging infectious diseases.

[4]  D. Stark,et al.  Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[5]  J. M. Sauder,et al.  Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. , 2009, Molecular and biochemical parasitology.

[6]  P. Brindley,et al.  Antimicrosporidial Activities of Fumagillin, TNP-470, Ovalicin, and Ovalicin Derivatives In Vitro and In Vivo , 2006, Antimicrobial Agents and Chemotherapy.

[7]  L. Weiss,et al.  Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. , 2005, Folia parasitologica.

[8]  L. Weiss,et al.  A review of the development of two types of human skeletal muscle infections from microsporidia associated with pathology in invertebrates and cold-blooded vertebrates. , 2005, Folia parasitologica.

[9]  L. Weiss,et al.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. , 2004, The New England journal of medicine.

[10]  S. Chevret,et al.  Fumagillin treatment of intestinal microsporidiosis. , 2002, The New England journal of medicine.

[11]  L. Weiss,et al.  TNP-470 is an effective antimicrosporidial agent. , 1998, The Journal of infectious diseases.

[12]  F. Derouin,et al.  In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi , 1994, Antimicrobial Agents and Chemotherapy.

[13]  H. Katznelson,et al.  Control of nosema disease of honeybees with fumagillin. , 1952, Science.